Although the mechanistic insights of CTGF in these tumors may be different, the current study may provide valuable guidance and treatment strategy targeting CTGF, TNFR1 and IκB in managing these metastatic tumors. The gene discussed is CCN2; the disease is metastatic neoplasm.